- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00016874 |
| 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer |
| completed |
| Phase 1 |
| — |
| Vion PharmaceuticalsINDUSTRY |
| 1 |
| Jul 18, 2013 |
| clinicaltrials |
| NCT00020618 | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain | completed | Phase 2 | — | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00021996 | Valdecoxib in Treating Chronic Pain in Cancer Patients | completed | N/A | — | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00036829 | Improving Pain Management in Patients With Nonhematologic Cancer | completed | N/A | — | Inflexxion, Inc.INDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | completed | Phase 1 | 17 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00004090 | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00045318 | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00301691 | Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet | completed | N/A | 2,000 | Brown UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00058071 | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | completed | Phase 3 | 100 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00072436 | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00331955 | Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00036777 | UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00003198 | Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00003197 | Green Tea Extract in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003555 | Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 20 | State University of New York - Upstate Medical UniversityOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003969 | Geldanamycin Analogue in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004881 | Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00024245 | 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003359 | T138067 Sodium in Treating Patients With Advanced Refractory Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003430 | L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003755 | Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003004 | Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | completed | Phase 1 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003242 | Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003630 | Arsenic Trioxide in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003742 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00003878 | Carmustine Implants in Treating Patients With Brain Metastases | completed | Phase 2 | — | New Approaches to Brain Tumor Therapy ConsortiumOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00004057 | Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005634 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00021164 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00059878 | Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006375 | LY293111 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00014365 | Ro 31-7453 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00016172 | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00004016 | Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors | completed | Phase 1 | — | University of RochesterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00074321 | Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors | completed | Phase 1 | 84 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00042900 | Pyroxamide in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00030368 | Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 77 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00047047 | Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 78 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00098501 | CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 18, 2013source: clinicaltrials